Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4 -Associated Stargardt Disease
Authors:
Open Access
- 2 March 2026
- journal article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 67 (3) , 6
Abstract
To assess cross-sectional and longitudinal relationships between fundus autofluorescence (FAF) and visual acuity (VA) in ABCA4-associated Stargardt disease (STGD1). Secondary analysis used data from 301 STGD1 participants (566 study eyes) enrolled in the international ProgStar studies. The study reading center graded the FAF images qualitatively and quantitatively, including areas of atrophy reflected as definitely decreased autofluorescence (DDAF) and questionably decreased autofluorescence (QDAF). Linear models estimated cross-sectional and longitudinal associations between the growth of DDAF area and total DAF area (i.e., sum of DDAF and QDAF areas) and change in VA. At the first visit, the median age was 30 years (range, 7-69); 55% were women. Mean ± SD VA was 0.73 ± 0.36 logMAR; mean total DAF area was 3.4 ± 3.8 mm2; and 42% of eyes had no DDAF. Cross-sectionally, increasing age and duration of symptoms, younger age of symptom onset, and larger QDAF area were significantly associated with worse VA (P < 0.05). Mean follow-up was 3.3 years (range, 0.5-10.3). There was no statistically significant relationship between growth of total DAF or DDAF areas and change in VA (P > 0.05). Characteristics other than DAF area (e.g., flecks presence) may influence VA. Some patients remained DDAF free longitudinally and thus would be excluded in STGD1 trials that use DDAF as the primary endpoint. The cross-sectional relationship between DAF and VA confirmed the association of VA with retinal pigment epithelium (RPE) structure. The lack of a significant association between growth in DAF areas with change in VA over follow-up points to challenges resulting from slow progression and large VA variability. Exploring outcome measures from other modalities is warranted for designing STGD1 trials.Keywords
This publication has 43 references indexed in Scilit:
- Macular Function and Morphologic Features in Juvenile Stargardt DiseaseOphthalmology, 2014
- The bisretinoids of retinal pigment epitheliumProgress in Retinal and Eye Research, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequenceHuman Molecular Genetics, 2004
- The genetics of inherited macular dystrophiesJournal of Medical Genetics, 2003
- Visual acuity loss and clinical observations in a large series of patients with stargardt diseaseOphthalmology, 2003
- A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophyNature Genetics, 1997
- Webvision: The Organization of the Retina and Visual System1995
- Human peripheral spatial resolution for achromatic and chromatic stimuli: limits imposed by optical and retinal factors.The Journal of Physiology, 1991
- Visual Acuity Loss in Patents with Stargardt's Macular DystrophyOphthalmology, 1987